D

Dayton Clinical Oncology Program | Wright-Patterson Medical Center

Research site
(Unclaimed)
Location
88 MPG 4881 Sugar Maple Drive, Wright-Patterson Air Force Base, Ohio, United States of America

Site insights

Top conditions

Top treatments

Paclitaxel
Bevacizumab
Carboplatin
Cisplatin
Docetaxel
Gemcitabine Hydrochloride
Ibrutinib
Crizotinib
Doxorubicin Hydrochloride
Anastrozole

Parent organization

This site is a part of Dayton Clinical Oncology Program

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 82 total trials

Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer

This randomized phase III trial studies enzalutamide to see how well it works compared to enzalutamide, abiraterone, and prednisone in treating patie...

Active, not recruiting
Hormone-resistant Prostate Cancer
Stage IV Prostate Cancer
Drug: prednisone
Drug: enzalutamide

The investigators hypothesize that the combination of eflornithine and sulindac will be effective in reducing a three-year event rate of adenomas and...

Active, not recruiting
Colorectal Neoplasms
Drug: eflornithine & sulindac placebo
Drug: Eflornithine placebo & sulindac placebo

The purpose of this study is to compare overall survival in newly diagnosed metastatic prostate cancer patients randomly assigned to androgen depriva...

Active, not recruiting
Prostate Cancer
Drug: Bicalutamide
Drug: TAK-700

Patients are enrolled to screening (Reg Step 1) prior to or after ASCT but prior to Reg Step 2. Patients are followed until they will begin Maintenan...

Enrolling
Multiple Myeloma
Drug: Lenalidomide
Drug: Daratumumab/rHuPH20

This phase III trial studies olaparib or cediranib maleate and olaparib to see how well they work compared with standard platinum-based chemotherapy...

Active, not recruiting
Recurrent Primary Peritoneal Carcinoma
Ovarian Undifferentiated Carcinoma
Drug: Gemcitabine
Drug: Cediranib Maleate

Trial sponsors

National Cancer Institute (NCI) logo
S
Alliance for Clinical Trials in Oncology logo
ECOG-ACRIN Cancer Research Group logo
G
G
N
R
N

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems